Potentiation of photodynamic therapy of cancer by complement: the effect of γ-inulin
Authors:
Open Access
- 5 December 2006
- journal article
- research article
- Published by Springer Nature in British Journal of Cancer
- Vol. 96 (1) , 67-72
Abstract
Host response elicited by photodynamic therapy (PDT) of cancerous lesions is a critical contributor to the clinical outcome, and complement system has emerged as its important element. Amplification of complement action was shown to improve tumour PDT response. In search of a clinically relevant complement activator for use as a PDT adjuvant, this study focused on γ-inulin and examined its effects on PDT response of mouse tumours. Intralesional γ-inulin (0.1 mg mouse−1) delivered immediately after PDT rivaled zymosan (potent classical complement activator) in delaying the recurrence of B16BL6 melanomas. This effect of γ-inulin was further enhanced by IFN-γ pretreatment. Tumour C3 protein levels, already elevated after individual PDT or γ-inulin treatments, increased much higher after their combination. With fibrosarcomas MCA205 and FsaR, adjuvant γ-inulin proved highly effective in reducing recurrence rates following PDT using four different photosensitisers (BPD, ce6, Photofrin, and mTHPC). At 3 days after PDT plus γ-inulin treatment, over 50% of cells found at the tumour site were CTLs engaged in killing specific targets via perforin–granzyme pathway. This study demonstrates that γ-inulin is highly effective PDT adjuvant and suggests that by amplifying the activation of complement system, this agent potentiates the development of CTL-mediated immunity against PDT-treated tumours.Keywords
This publication has 29 references indexed in Scilit:
- Photodynamic therapy and anti-tumour immunityNature Reviews Cancer, 2006
- PDT‐associated host response and its role in the therapy outcomeLasers in Surgery and Medicine, 2006
- Role of Complement Anaphylatoxin C3a in Photodynamic Therapy‐elicited Engagement of Host Neutrophils and Other Immune CellsPhotochemistry and Photobiology, 2006
- Characteristics of complement activation in mice bearing Lewis lung carcinomas treated by photodynamic therapyCancer Letters, 2005
- The complement system in regulation of adaptive immunityNature Immunology, 2004
- Adjuvant treatment for complement activation increases the effectiveness of photodynamic therapy of solid tumorsPhotochemical & Photobiological Sciences, 2004
- Interferon-γ: an overview of signals, mechanisms and functionsJournal of Leukocyte Biology, 2003
- The adjuvanticity of gamma inulinImmunology & Cell Biology, 1988
- Anti-complementary action of polymorphic “solubility forms” of particulate inulinMolecular Immunology, 1986
- The anti-melanoma activity of inulin in miceMolecular Immunology, 1986